Vice President Ann Baker will moderate a session entitled “Covering all the bases: An integrated approach to strategic drug development.” John Cole will facilitate BIO-Europe’s Academic Innovators track, a series of presentations designed to bridge the gap and encourage collaboration between academia and the biopharma industry.
CRA is a silver sponsor and exhibitor for this annual conference. Visit us at booth #27.
For more information on this event, click here.
Strategies for combination therapy in oncology: Part two – Working with the “status quo”
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In...